Hematology - Medical Oncology Clinical Trials Resources

Listed below are the Hematology - Medical Oncology Clinical Trials offered at the Kaiser Permanente Santa Clara Medical Center.

Title: A RANDOMIZED PHASE III TRIAL OF CC-5013 (LENALIDOMIDE, NSC-703813) AND LOW DOSE DEXAMETHASONE (LLD) VERSUS BORTEZOMIB (PS-341, NSC-681239), LENALIDOMIDE AND LOW DOSE DEXAMETHASONE (BLLD) FOR INDUCTION, IN PATIENTS WITH PREVIOUSLY UNTREATED MULTIPLE MYELOMA WITHOUT AN INTENT FOR IMMEDIATE AUTOLOGOUS STEM CELL TRANSPLANT.
Phase: III
Protocol Number: S0777
Sponsors and Collaborators: Clinical Trials Support Unit (CTSU)
Weblink: LINK TO THE WEB SITE
Title: STUDY OF BONE MARROW AND BLOOD SAMPLES FROM PATIENTS WITH LEUKEMIA OR OTHER HEMATOPOIETIC CANCERS.
Phase: Observational
Protocol Number: S9007
Sponsors and Collaborators: Southwest Oncology Group (SWOG)
Weblink: LINK TO THE WEB SITE
Title: DASATINIB IN CHRONIC MYELOGENOUS LEUKEMIA OR PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIC SUBJECTS WHO ARE EXPERIENCING CLINICAL BENEFIT ON CURRENT START PROTOCOLS: LONG TERM SAFETY AND EFFICACY ANALYSIS.
Phase: N/A
Protocol Number: CA180188
Sponsors and Collaborators:

Bristol-Myers Squibb (BMS)

Weblink: LINK TO THE WEB SITE

 

 

 

 

 

 

 

TOP

Santa Clara

Comprehensive Cancer Care